New Drug Shrinks Prostate Tumors in 82% of Trial Patients

A groundbreaking immunotherapy drug has shown stunning results in early trials, shrinking tumors in men with advanced prostate cancer who had run out of treatment options.

Researchers believe this breakthrough could eventually lead to cures for a disease that affects 1.

5 million men worldwide each year.